Tag: CHECKMATE-274

Home / CHECKMATE-274

Categories

Nivolumab has been approved by the FDA for use as an adjuvant treatment for urothelial carcinoma

August 2021: Nivolumab (Opdivo, Bristol-Myers Squibb Co.) has been approved by the Food and Drug Administration for the adjuvant treatment of patients with urothelial carcinoma (UC) who are at high ri...
checkmate-274

Scan the code